The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. METHOD: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. RESULTS: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. CONCLUSION: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is significant contributor to the global burden of disease [7, 43].”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anxiety disorders cause 10.4% of the Disability Adjusted Life Years (DALYs) lost due to neurological, mental, substance use disorders and account for 1.1% of the global burden of disease worldwide, that is a total of 26,800,000 DALYs worldwide (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015).”
From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As described above, postpartum psychosis is a key marker for the risk of future affective disorder”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“In 2010, mental, neurological and substance abuse disorders accounted for 10.4% of all disability-adjusted life-years globally.21”
From Climate change, climate-related disasters and mental disorder in low- and middle-income countries: a scoping review (2021) · cites this paper as [21]
In the citing paper
“Recent prevalence estimates indicate 10.7% of the world’s population live with a mental health disorder, and the number of years lived with a mental health disorder has increased by 13.5% from 2007 to 2017”
From Explaining adults’ mental health help-seeking through the lens of the theory of planned behavior: A scoping review (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 7×
“Overall, GBD 2010 findings highlighted a shift in burden from communicable to noncommunicable diseases and from YLLs to YLDs [1,11].”
InfluentialSelf-citationVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationWorld Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
(1996) · Cited by 6,884
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Self-citationDiagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Self-citation
Cited by
Items 201–300 of 1,000
Ruzek, J. I., & Yeager, C. M. (2017) · Global Mental Health · doi:10.1017/gmh.2017.11 · Cited by 54
“Mental health disorders are the leading cause of global disability burden (Whiteford et al. 2015), accounting for about 14% of the global burden of disease (World Health Organization, 2010).”
BackgroundMuñoz‐Navarro, R., Medrano, L. A., Limonero, J. T., González‐Blanch, C., Moriana, J. A., Ruiz‐Rodríguez, P., & Vindel, A. C. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.029 · Cited by 59
Belouin, S. J., Averill, L. A., Henningfield, J. E., Xenakis, S. N., Donato, I., Grob, C. S., Berger, A., Magar, V., Danforth, A. L., & Anderson, B. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109214 · Cited by 59
Thornicroft, G., & Semrau, M. (2019) · BJPsych Open · doi:10.1192/bjo.2019.9 · Cited by 53
Boosting psychological change: Combining non-invasive brain stimulation with psychotherapy
Tatti, E., Phillips, A., Paciorek, R., Romanella, S. M., Dèttore, D., Lorenzo, G. D., Ruffini, G., Rossi, S., & Santarnecchi, E. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104867 · Cited by 58
Effects of cannabis smoking on the respiratory system: A state-of-the-art review
Khoj, L., Zagà, V., Amram, D. L., Hosein, K., Pistone, G., Bisconti, M., Serafini, A., Cammarata, L. M., Cattaruzza, M. S., & Mura, M. (2023) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107494 · Cited by 60
HDL-cholesterol and apolipoproteins in relation to dementia
Koch, M., & Jensen, M. K. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000257 · Cited by 60
Werlen, L., Puhan, M. A., Landolt, M. A., & Mohler‐Kuo, M. (2020) · BMC Public Health · doi:10.1186/s12889-020-09577-6 · Cited by 57
“In addition, CMDs constitute one of the leading causes of disability-adjusted life years (DALYs) [2], and CMDs’ global burden continues to grow over time [3]: by 2030, depression is predicted to become the leading cause of disability in high-income countries [4].”
BackgroundMurphy, J., Viding, E., & Bird, G. (2019) · Psychological Review · doi:10.1037/rev0000158 · Cited by 52
“If, as the evidence suggests, high TIPE is more common in women, it is therefore possible that high TIPE may partly explain why anxiety disorders are more common in women than men (Whiteford et al., 2015).”
BackgroundInfluentialHasan, F., Foster, M. M., & Cho, H. (2023) · Journal of Health Communication · doi:10.1080/10810730.2023.2235563 · Cited by 63
Scarpazza, C., Ha, M., Baecker, L., Garcia‐Dias, R., Pinaya, W. H. L., Vieira, S., & Mechelli, A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0798-6 · Cited by 54
Thibaudeau, É., Cellard, C., Turcotte, M., & Achim, A. M. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa182 · Cited by 51
Depressive Symptoms in Pregnancy: The Influence of Social, Psychological and Obstetric Aspects
Campos, R., Avelino, M. M., & de Moraes, E. V. (2016) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0036-1585072 · Cited by 51
“13 On the other hand, social support can mitigate depressive episodes, particularly in the presence of physiological and psychosocial changes, such as in pregnancy.”
The shame spiral of addiction: Negative self-conscious emotion and substance use
Batchelder, A., Glynn, T. R., Moskowitz, J. T., Neilands, T. B., Dilworth, S. E., Rodriguez, S. L., & Carrico, A. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265480 · Cited by 56
Smeland, O. B., Kutrolli, G., Bahrami, S., Fominykh, V., Parker, N., Fuhrer, J., Hindley, G., Rødevand, L. N., Jaholkowski, P. P., Tesfaye, M., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02090-2 · Cited by 67
“Across all phenotypes, 1,988 grouped loci and 7,829 genes were identified.”
The Microbiome and Mental Health: Looking Back, Moving Forward with Lessons from Allergic Diseases
Logan, A. C., Jacka, F. N., Craig, J. M., & Prescott, S. L. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.2.131 · Cited by 51
Ruiz-Rodríguez, P., Cano-Vindel, A., Muñoz Navarro, R., Medrano, L., Moriana, J. A., Buiza Aguado, C., Jiménez Cabré, G., & González-Blanch, C. (2017) · Ansiedad y Estrés · doi:10.1016/j.anyes.2017.10.003 · Cited by 50
Chen, S., Jiang, H., Liu, Y., Hou, Z., Yue, Y., Zhang, Y., Zhao, F., Xu, Z., Li, Y., Mou, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06832-6 · Cited by 50
Pearson, R. M., Campbell, A., Howard, L. M., Bornstein, M. H., O'Mahen, H., Mars, B., & Moran, P. (2018) · Psychological Medicine · doi:10.1017/s0033291717001246 · Cited by 41
“Common mental disorders, notably depression, are among the leading causes of global disease burden (Whiteford et al. 2015).”
BackgroundADGRL3 (LPHN3) variants predict substance use disorder
Arcos‐Burgos, M., Velez, J. I., Martinez, A. F., Ribasés, M., Ramos‐Quiroga, J. A., Sánchez‐Mora, C., Richarte, V., Roncero, C., Cormand, B., Fernàndez‐Castillo, N., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0396-7 · Cited by 55
Vaingankar, J. A., Chong, S. A., Abdin, E., Devi, F., Chua, B. Y., Sambasivam, R., Shafie, S., Jeyagurunathan, A., Seow, E., & Subramaniam, M. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01308-0 · Cited by 50
“The impact of mental disorders on overall health and quality of life is well known [4].”
BackgroundNon-invasive cortical stimulation: Transcranial direct current stimulation (tDCS)
Sudbrack-Oliveira, P., Razza, L. B., & Brunoni, A. R. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2021.01.001 · Cited by 62
Tsamantioti, E., Lisonkova, S., Muraca, G. M., Örtqvist, A. K., & Razaz, N. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.03.028 · Cited by 59
Uddin, M. S., Al Mamun, A., Asaduzzaman, M., Hosn, F., Abu Sufian, M., Takeda, S., Herrera-Calderon, O., Abdel-Daim, M. M., Uddin, G. M. S., Noor, M. A. A., et al. (2018) · Annals of Neurosciences · doi:10.1159/000481812 · Cited by 48
Younis, N. M. (2022) · Bionatura · doi:10.21931/rb/2022.07.02.35 · Cited by 49
Managing Alcohol Use Disorder in Primary Health Care
Anderson, P., O'Donnell, A. J., & Kaner, E. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0837-z · Cited by 53
Sharpe, I., & Davison, C. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052896 · Cited by 48
“In 2010, the Global Burden of Disease study found that mental, neurological, and substance abuse disorders accounted for over 10% of all disability-adjusted life years [29].”
BackgroundGenealogies and anthropologies of global mental health
Lovell, A. M., Read, U. M., & Lang, C. (2019) · Culture, Medicine, and Psychiatry · doi:10.1007/s11013-019-09660-7 · Cited by 48
“Re-analyses have since placed mental, neurological and substance use-related disorders (MNS) as the leading source of years lost to disability in the world (Whiteford et al. 2015).”
BackgroundMutiso, V., Gitonga, I., Musau, A., Musyimi, C. W., Nandoya, E., Rebello, T. J., Pike, K. M., & Ndetei, D. M. (2018) · International Journal of Mental Health Systems · doi:10.1186/s13033-018-0234-y · Cited by 47
del Campo, C. M. Z.-M., Rosas, M., & Guarner‐Lans, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041224 · Cited by 46
“4% of all mental and substance abuse diseases [6].”
BackgroundJohansson, O., Bjärehed, J., Andersson, G., Carlbring, P., & Lundh, L.-G. (2019) · Internet Interventions · doi:10.1016/j.invent.2019.100247 · Cited by 43
Social Work Education and Training in Mental Health, Addictions, and Suicide: A Scoping Review
Kourgiantakis, T., Sewell, K. M., McNeil, S., Lee, E., Logan, J., Kuehl, D., McCormick, M., Adamson, K., & Kirvan, A. (2022) · Journal of Social Work Education · doi:10.1080/10437797.2020.1773363 · Cited by 45
Vally, Z., Cody, B. L., Albloshi, M. A., & Alsheraifi, S. N. M. (2018) · Perspectives in Psychiatric Care · doi:10.1111/ppc.12282 · Cited by 45
Regional research priorities in brain and nervous system disorders
Ravindranath, V., Dang, H., Goya, R. G., Mansour, H., Nimgaonkar, V. L., Russell, V. A., & Yu, X. (2015) · Nature · doi:10.1038/nature16036 · Cited by 48
LaMontagne, A. D., Milner, A. J., Allisey, A., Page, K. M., Reavley, N. J., Martin, A. J., Tchernitskaia, I., Noblet, A. J., Purnell, L. J., Witt, K., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0741-9 · Cited by 50
“Ethics approval was granted by Human Ethics Advisory Group at the School of Population and Global Health at the University of Melbourne (ethics number: 1340429) and the Human Ethics Committee at Deakin University (Melbourne, Australia) (ethics number: 2014- 132), as well as approval from Victoria Police.”
BackgroundInfluentialLiu, G., Zhang, N., Teoh, J. Y., Egan, C., Zeffiro, T. A., Davidson, R. J., & Quevedo, K. (2020) · Psychological Medicine · doi:10.1017/s0033291720002482 · Cited by 45
Bennett, D. A., Brayne, C., Feigin, V. L., Barker-Collo, S., Brainin, M., Davis, D., Gallo, V., Jetté, N., Karch, A., Kurtzke, J. F., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0034-5 · Cited by 45
“Neurological diseases are becoming more prevalent as the world’s population ages and their burden is expected to increase globally [1].”
BackgroundSelf-citationCognitive Behavioral Therapy Lowers Elevated Functional Connectivity in Depressed Adolescents
Chattopadhyay, S., Tait, R., Simas, T., van Nieuwenhuizen, A., Hagan, C. C., Holt, R. J., Graham, J., Sahakian, B. J., Wilkinson, P. O., Goodyer, I. M., et al. (2017) · eBioMedicine · doi:10.1016/j.ebiom.2017.02.010 · Cited by 43
“Major depressive disorder (MDD) is a leading cause of disability (Whiteford et al., 2015).”
BackgroundMethodBrohan, E., Chowdhary, N., Dua, T., Barbui, C., Thornicroft, G., Kestel, D., Ali, A., Assanangkornchai, S., Brodaty, H., Carli, V., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00370-x · Cited by 44
Depressive Symptoms Predict Major Depressive Disorder after 15 Years among Whites but Not Blacks
Moazen-Zadeh, E., & Assari, S. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00013 · Cited by 44
“J Racial Ethn Health Disparities (2015) 2(1):1–13.”
BackgroundInfluentialNeurogenomics in Africa: Perspectives, progress, possibilities and priorities
Akinyemi, R., Owolabi, M. O., Oyeniyi, T. A., Ovbiagele, B. I., Arnett, D. K., Tiwari, H. K., Walker, R. W., Ogunniyi, A. O., & Kalaria, R. N. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.006 · Cited by 49
“Epilepsy is a common neurological disease [6, 93], particularly, in sub-Saharan Africa.”
BackgroundHaddad, M., Waqas, A., Qayyum, W., Shams, M., & Malik, S. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1069-1 · Cited by 45
A Review of Asenapine in the Treatment of Bipolar Disorder
Vieta, E., & Montes, J. M. G. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0592-2 · Cited by 45
Mental Health Apps in China: Analysis and Quality Assessment
Shang, J., Wei, S., Jin, J., & Zhang, P. (2019) · JMIR mhealth and uhealth · doi:10.2196/13236 · Cited by 45
Fischer, B., Varatharajan, T., Shield, K. D., Rehm, J. T., & Jones, W. R. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.024 · Cited by 44
Urban public parks and mental health in adult women: Mediating and moderating factors
Bojórquez, I., & Ojeda-Revah, L. (2018) · International Journal of Social Psychiatry · doi:10.1177/0020764018795198 · Cited by 49
Impact of depressive symptoms on worklife expectancy: a longitudinal study on Danish employees
Pedersen, J., Thorsen, S. V., Andersen, M. F., Hanvold, T. N., Schlünssen, V., & Bültmann, U. (2019) · Occupational and Environmental Medicine · doi:10.1136/oemed-2019-105961 · Cited by 45
Welfarist psychiatry goes global
McConnell, D., & Savulescu, J. (2020) · Global Mental Health and Neuroethics · doi:10.1016/b978-0-12-815063-4.00004-6 · Cited by 3
“…problems represent a significant proportion of the global burden of disease (~10% disability-adjusted life years) yet receive a disproportionately low level of funding (less than 1% of most countries’ healthcare budget) (Patel et al., 2016; Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015).”
Family-Focused Practices in Addictions: A Scoping Review
Kourgiantakis, T., Ashcroft, R., Mohamud, F., Fearing, G., & Sanders, J. (2021) · Journal of Social Work Practice in the Addictions · doi:10.1080/1533256x.2020.1870287 · Cited by 53
Reardon, C. L., Gorczynski, P. F., Hainline, B. W., Hitchcock, M., & Rice, S. (2023) · Clinics in Sports Medicine · doi:10.1016/j.csm.2023.06.002 · Cited by 47
Masimirembwa, C. M., Dandara, C., & Leutscher, P. D. C. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0120 · Cited by 42
“The global burden of mental and neurological diseases, for 2010, shows that sub-Sahara Africa presents with one of the highest incidence of neurological disorders (Whiteford et al., 2015).”
Sundrum, T., & Walker, C. S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14053 · Cited by 62
“The prevalence of migraine continues to rise, and it is currently estimated that migraine effects over 1 billion people worldwide and is rated as the sixth highest cause of disability worldwide by the World Health Organization (Whiteford et al., 2015).”
BackgroundStigma associated with mental illness among Asian men in Vancouver, Canada
Livingston, J., Patel, N. B., Bryson, S. A., Hoong, P., Lal, R., Morrow, M., & Guruge, S. (2018) · International Journal of Social Psychiatry · doi:10.1177/0020764018805125 · Cited by 45
Process evaluation of a district mental healthcare plan in Nepal: a mixed-methods case study
Luitel, N. P., Breuer, E., Adhikari, A., Kohrt, B. A., Lund, C., Komproe, I. H., & Jordans, M. J. D. (2020) · BJPsych Open · doi:10.1192/bjo.2020.60 · Cited by 41
Occurrence, mortality and cost of brain disorders in Denmark: a population-based cohort study
Vestergaard, S. V., Rasmussen, T. B., Stallknecht, S. E., Olsen, J., Skipper, N., Sørensen, H. T., & Christiansen, C. F. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037564 · Cited by 47
Elias, G. J. B., Boutet, A., Parmar, R., Wong, E. H. Y., Germann, J., Loh, A., Paff, M. R., Pancholi, A., Gwun, D., Chow, C. T., et al. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.08.021 · Cited by 42
“This research focus may simply reflect the fact that depression is the top cause of mental healthrelated disease burden worldwide, with major depressive disorder and dysthymia together affecting at least 400 million people [37,52].”
Backgroundvan Rensburg, A. J., & Fourie, P. (2016) · International Journal of Mental Health Systems · doi:10.1186/s13033-016-0081-7 · Cited by 46
Handgrip strength is associated with suicidal thoughts in men: Cross‐sectional analyses from NHANES
Cao, C., Liu, Q., Yang, L., Zheng, X., Lan, P., Koyanagi, A., Vancampfort, D., Soysal, P., Veronese, N., Stubbs, B., et al. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13559 · Cited by 42
Soda, T., McLoughlin, D. M., Clark, S. R., Oltedal, L., Keßler, U., Haavik, J., Bousman, C., Smıth, D. J., Bioque, M., Clements, C. C., et al. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01087-w · Cited by 42
“1 3 impairment attributed to mental health disorders [71].”
BackgroundGandy, M., Karin, E., McDonald, S., Meares, S., Scott, A. J., Titov, N., & Dear, B. F. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110173 · Cited by 36
Hensel, J. M., Shaw, J., Ivers, N. M., Desveaux, L., Vigod, S. N., Cohen, A., Onabajo, N., Agarwal, P., Mukerji, G., Yang, R., et al. (2019) · Journal of Medical Internet Research · doi:10.2196/10838 · Cited by 39
“In addition, mental and substance use disorders are emerging as a leading cause of disability, accounting for nearly 10% of global disability-adjusted life years [1].”
Angdembe, M., Kohrt, B. A., Jordans, M., Rimal, D., & Luitel, N. P. (2017) · International Journal of Mental Health Systems · doi:10.1186/s13033-017-0176-9 · Cited by 39
SCZ-SCAN: An automated Schizophrenia detection system from electroencephalogram signals
Sahu, G., Karnati, M., Gupta, A., & Seal, A. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105206 · Cited by 39
A comprehensive regional analysis of genome-wide expression profiles for major depressive disorder
Forero, D. A., Guio-Vega, G. P., & González‐Giraldo, Y. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.061 · Cited by 43
“INTRODUCTION Major depressive disorder (MDD) is a main challenge for psychiatric research around the world, with an estimated global lifetime prevalence of around 11.2% (Whiteford et al., 2015).”
BackgroundMethodInfluentialA systematic review of stakeholder perceptions of supervised injection facilities
Lange, B. C. L., & Bach‐Mortensen, A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.006 · Cited by 43
Stroud, C., Onnela, J.-P. “., & Manji, H. K. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0123-z · Cited by 39
Rose, M., Filiatreault, A., Guénette, J., Williams, A., & Thomson, E. M. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109483 · Cited by 39
Life negative events and depressive symptoms: the China longitudinal ageing social survey
Wang, Z., Yang, H., Zheng, P., Liu, B., Guo, Z., Geng, S., & Hong, S. (2020) · BMC Public Health · doi:10.1186/s12889-020-09119-0 · Cited by 42
Kaman, A., Otto, C., Klasen, F., Westenhöfer, J., Reiß, F., Hölling, H., & Ravens‐Sieberer, U. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.036 · Cited by 42
Adewuya, A. O., Ola, B. A., Coker, O., Atilola, O., Fasawe, A., & Ajomale, T. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.07.012 · Cited by 38
Asim, M., Sathian, B., van Teijlingen, E., Mekkodathil, A. A., G, R. B. M., Elayedath, R., Kumar, R. N., Simkhada, P. P., & Banerjee, I. (2022) · Nepal Journal of Epidemiology · doi:10.3126/nje.v12i2.46334 · Cited by 42
Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target
Calabrese, F., Riva, M. A., & Molteni, R. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1188080 · Cited by 38
“health economic challenge all over the world [166].”
BackgroundKautzky, A., James, G. M., Philippe, C., Baldinger-Melich, P., Kraus, C., Kranz, G. S., Vanicek, T., Gryglewski, G., Wadsak, W., Mitterhauser, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.108 · Cited by 35
“…Dif fi culties to track these effects down in a clinical sample might derive from compensational regulation of 5-HT, increasingly so as in Deaf1 knockout mice a more prominent role of other factors as Pet and Freud1 and 2 that are usually overshadowed by Deaf1 has been reported by the same group.”
BackgroundCognitive Impairment Along the Course of Depression: Non-Pharmacological Treatment Options
Listunova, L., Roth, C., Bartolovic, M., Kienzle, J., Bach, C., Weisbrod, M., & Roesch-Ely, D. (2018) · Psychopathology · doi:10.1159/000492620 · Cited by 44
Kourgiantakis, T., Sewell, K. M., Lee, E., Adamson, K., McCormick, M., Kuehl, D., & Bogo, M. (2019) · Journal of Social Work Education · doi:10.1080/10437797.2019.1656590 · Cited by 44
Yeshanew, B., Belete, A., & Necho, M. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00261-y · Cited by 44
Boden-Albala, B. M., Stillman, J. I., Roberts, E. T., Quarles, L. W., Glymour, M. M., Chong, J. Y., Moats, H. L., Torrico, V., & Parides, M. (2015) · Stroke · doi:10.1161/strokeaha.114.008502 · Cited by 38
Muñoz‐Navarro, R., Vindel, A. C., Ruiz‐Rodríguez, P., Medrano, L. A., González‐Blanch, C., Moriana, J. A., Bonet, A. C., & Dongil, E. (2017) · Ansiedad y Estrés · doi:10.1016/j.anyes.2017.10.002 · Cited by 45
“Los trastornos mentales no diagnosticados representan un desafío importante y un costo significativo para la sociedad española (Parés Badell et al., 2014), como en otros países (Whiteford et al., 2015).”
BackgroundGriffiths, K. M., Bennett, K., Walker, J., Goldsmid, S., & Bennett, A. (2016) · Internet Interventions · doi:10.1016/j.invent.2016.09.004 · Cited by 30
“Mental disorders are the leading cause of disability burden worldwide accounting for 23% of all years lived with disability (Whiteford et al., 2015).”
BackgroundPublication trends in transcranial magnetic stimulation: a 30-year panorama
McLean, A. L. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.01.002 · Cited by 39
Mangolini, V. I., Andrade, L. H., Neto, F. L., & Wang, Y. (2019) · Clinics · doi:10.6061/clinics/2019/e1316 · Cited by 41
Tol, W. A., Greene, M. C., Lasater, M. E., Roch, K. L., Bizouerne, C., Purgato, M., Tomlinson, M., & Barbui, C. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020000864 · Cited by 38
Karpov, B., Joffe, G., Aaltonen, K. I., Suvisaari, J., Baryshnikov, I., Näätänen, P., Koivisto, M., Melartin, T. K., Oksanen, J., Suominen, K. H., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.03.010 · Cited by 42
Roessner, V., Rothe, J., Kohls, G., Schomerus, G., Ehrlich, S., & Beste, C. (2021) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01836-0 · Cited by 40
Examination of the influence of social capital on depression in fragile families
Wilmot, N. A., & Dauner, K. N. (2016) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2016-207544 · Cited by 41
Tomczyk, S., Schomerus, G., Stolzenburg, S., Muehlan, H., & Schmidt, S. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1537-7 · Cited by 40
Mohebbi, E., Haghdoost, A. A., Noroozi, A., Vardanjani, H. M., Hajebi, A., Nikbakht, R., Mehrabi, M., Jabbarinejad-Kermani, A., Salemianpour, M., & Baneshi, M. R. (2018) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2018.128 · Cited by 36
Cognitive rigidity in patients with depression and fibromyalgia
Aguilera, M., Paz, C., Compañ, V., Medina, J. C., & Feixas, G. (2019) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2019.02.002 · Cited by 43
“9 o 2 g o n a p h d fi M P T t o t p M w o A t S t I Depressive disorder is one of the most severe health problems in our society because of its disabling effects, and societal and economic burden (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015).”
BackgroundKourgiantakis, T., Sewell, K. M., McNeil, S. R., Logan, J. R., Lee, E., Adamson, K., McCormick, M., & Kuehl, D. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024659 · Cited by 40
Abd-Alrazaq, A. A., Malkawi, A. A., Maabreh, A. H., Alam, T., Bewick, B. M., Akhu‐Zaheya, L., & Househ, M. S. (2020) · Research Square · doi:10.21203/rs.3.rs-44376/v1 · Cited by 38
Lokkerbol, J., Wijnen, B. F. M., Ruhé, H. G., Spijker, J., Morad, A., Schoevers, R. A., de Boer, M. K., Cuijpers, P. J., & Smit, F. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1844566 · Cited by 39
Strassnig, M., Cornacchio, D., Harvey, P. D., Kotov, R., Fochtmann, L. J., & Bromet, E. J. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.011 · Cited by 35
“Severe and persistent mental illnesses (SPMI), including schizophrenia (SCZ) and bipolar disorder (BP), are associated with high rates of disability in the US and worldwide (Kim et al., 2010; Murray et al., 2013; Whiteford et al., 2010).”
Milner, A. J., Scovelle, A. J., & King, T. L. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000367 · Cited by 36
Scientific productivity in neurosciences in Latin America: a scientometrics perspective
Forero, D. A., Trujillo‐Güiza, M. L., González‐Giraldo, Y., & Barreto, G. E. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1692837 · Cited by 35
Neill, R. D., Lloyd, K., Best, P., & Tully, M. A. (2020) · Mental health and physical activity · doi:10.1016/j.mhpa.2020.100359 · Cited by 38
Livne, O., Shmulewitz, D., Sarvet, A. L., Wall, M. M., & Hasin, D. S. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21010073 · Cited by 37
Streibelt, M., Bürger, W., Nieuwenhuijsen, K., & Bethge, M. (2017) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-017-9709-y · Cited by 39
A systematic literature review and analysis of deep learning algorithms in mental disorders
Arji, G., Erfannia, L., Alirezaei, S., & Hemmat, M. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101284 · Cited by 35
Depressive symptoms and drug use among nursing staff professionals
Junqueira, M. A. D. B., dos Santos, M. A., de Araújo, L. B., Ferreira, M. C. D. M., Giuliani, C. D., & Pillon, S. C. (2018) · Escola Anna Nery · doi:10.1590/2177-9465-ean-2018-0129 · Cited by 35
Chibanda, D., Abas, M., Musesengwa, R., Merritt, C., Sorsdahl, K. R., Mangezi, W. O., Bandawe, C., Cowan, F. M., Araya, R., Gomo, E., et al. (2020) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2019.32 · Cited by 37
Metadata
- Authors
- Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T.
- Affiliations
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Auckland University of Technology (NZ)
- University of Washington (US)
- Corresponding author
- Whiteford, Harvey A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-06
- Volume
- 10
- Issue
- 2
- Pages
- e0116820
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4320057
- OpenAlex
- W2006103193
- Semantic Scholar
- 29fdb08fe359a077ba5ecfea8813becf7defce8c
- Cited by
- 1,175
- References
- 47
- Citations by year
- 2026: 34 · 2025: 63 · 2024: 83 · 2023: 111 · 2022: 121 · 2021: 142 · 2020: 145 · 2019: 143 · 2018: 123 · 2017: 113 · 2016: 66 · 2015: 29
- FWCI
- 180.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bill and Melinda Gates Foundation
- Australian Government
- University of New South Wales
- Medical Research Council
- National Health and Medical Research Council (1041742)
- National Drug and Alcohol Research Centre
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- mental illness, neurological disorders, substance use disorders, global burden of disease, disability-adjusted life years, years lived with disability, prevalence trends, sex differences, age differences, regional variation, schizophrenia, Parkinson's disease, epilepsy
- MeSH terms
- Age Factors, Bayes Theorem, Mental Disorders, Female, Geography, Humans, Male, Nervous System Diseases, Regression Analysis, Time Factors, Global Health, Prevalence, Cost of Illness, Quality-Adjusted Life Years, Substance-Related Disorders, Mortality, Premature
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.